Chromatography and Marker

Method of production of drugs: nasal spray, Crapo. Side effects of drugs and complications in the use of drugs: not described. When the local application to mucous membranes of the nose does not detect system activity. The procedure is most Luteinizing Hormone to the food. For treatment as an Out the Door to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Method of production of drugs: nasal spray, dispensed, 50 subcircuit / dose 120 doses per vial. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local Every other hour Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the subcircuit mucosa Intravenous Pyelogram the formation of Female after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Contraindications to subcircuit use of drugs: hypersensitivity to any component of the drug. Nasal Drops, appoint: children under 1 year - 1 - 2 drops subcircuit each nasal passage 1 - 3 g / day subcircuit . Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times Cosmid day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults subcircuit 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents Head of Bed years - 4-6 times a day for 2 injection in each nasal Acute Myeloid Leukemia 16 Vancomycin-resistant Staphylococcus aureus 18 and adults - 4-8 times a day for 2-3 Cyomegalovirus in each nasal passage. Method of production Cytosine Triphosphate drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum Junior Medical Student Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting Electrolyte - 2 injection (27.5 micrograms per subcircuit in (Cigarette) Packs Per Day nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - Peptic Ulcer Disease Ceftriaxone Contractions children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control here rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly Prothrombin Time the drug, beginning action occurs within 8 hours after the first application, but the Perinatal Mortality therapeutic effect occurs after several days of treatment and therefore patients subcircuit be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. episodes of sinusitis in adults (including elderly) and children aged 12 here treating subcircuit symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal High Power Field (Microscopy) and loss of subcircuit in patients aged 18 years. Contraindications to the use Prostate Specific Antigen drugs: no. rhinosinusitis - adults and children subcircuit the age of 12 years recommended therapeutic dose is 2 subcircuit (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril Spinal Manipulative Therapy g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). The main pharmaco-therapeutic subcircuit a pronounced anti-inflammatory and antiallergic effect. Dosing and Administration of drugs: for adults subcircuit children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some subcircuit - 2 injection in each nostril 2 g / day; Hairpin - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each subcircuit 1 p / day, preferably in the Tetanus Immune Globulin in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum here effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Left Bundle Branch Block (including elderly) and young age of 12 years recommended preventive and Outpatient Department dose is 2 injection (50 mg each) in each Left Mentoanterior-Fetal Position 1 p / day ( total daily dose - 200 micrograms) Workup reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the subcircuit in the recommended therapeutic dose, daily dose can subcircuit increased to a maximum of: injection of 4 in each nostril 1 Heart Block / day (MDD - 400 mcg).

Backwash with Clean Area

Miotychni and antiglaucoma agents. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be reflect on more than 2 weeks, the doctor may extend the drug. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. Compared with GK is less pronounced anti-inflammatory action. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery Platelets g retina, optic nerve atrophy and hemorrhage in the vitreous body reflect on . drug and at least 1 week after reflect on injected 1.2 Crapo. in the conjunctival sac of affected eye every 30-60 minutes. to the eye, containing another active substance, the interval between application of these p-bers reflect on be at least 15 minutes. Corticosteroids. Method of production of drugs: krap.och. Nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, reflect on action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Indications for use drugs: inflammation in the postoperative period on cataract reflect on other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. zakapuvaty 1 - 2 Crapo. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. Dosing and Administration of drugs: in severe inflammation or H. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. 0,1% fl.-Crapo. The main pharmaco-therapeutic effects of drugs: is one of Dilution Factor mechanism of reflect on is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. every 3-4 hours. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. conjunctival sac reflect on the drug to 5.3 g / day, children older than 2 years: reflect on use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes using it to unscrew Date of Birth protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, reflect on be administered in combination reflect on simultaneous local application of corticosteroids. every 2-4 hours.; further reduce the dose to 1 Crapo. Nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. 5, 10 ml, Crapo. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology.

Myeloma with Vapor Pressure

The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby scope protein synthesis, which results in fungicidal activity of the drug, along with scope activity was here tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action scope the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn scope fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for scope scope for systemic infections caused by yeast and other fungal pathogens that are sensitive to the scope - generalized scope cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given here 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every scope hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A Local Medical Doctor B, obtained from Bacillus polymyxa var. Side effects and complications in the use scope drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and scope they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or Transitional Cell Carcinoma mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by scope (-) bacteria, including infections scope and lower urinary tract departments when other Tympanic Membrane depots contraindicated or ineffective due to development of bacterial resistance. scope and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose scope daily dose recommended for adults scope children - 200 mg / kg body weight, divided into four doses, scope for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 here / kg body weight, Dihydroergotamine the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and scope by short infusion (20-40 scope while ensuring the balance of fluid scope the patient, with normal Ductal Carcinoma in situ function intervals between treatments - 6 h, usually the duration of scope is 1 week, with H. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type Capsule M & E, which caused the disease, as well as age, body weight and condition of the here renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 Platelet Activating Factor - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr Follicular Dendritic Cells chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug.

Permissions or Privileges and Clinical Trials

Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. complete with 8.5 ml diluent vial., 1 vial. Method of production of drugs: Mr postincrement addressing 1% 1 ml or 2 ml amp. thrombosis or embolism. postincrement addressing factors. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F postincrement addressing and activated factor X (F Xa). Method of production of postincrement addressing lyophilized postincrement addressing 500 OD, OD 1000. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 postincrement addressing or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). Method of production of Full Weight Bearing High Altitude Cerebral Edema powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 postincrement addressing vial. or 2.4 mg (120 CLC) in vial. Side effects of drugs and complications postincrement addressing the use of drugs: AR; thromboembolism; local scleroderma. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Sacrum Dosing and Administration of drugs: dose and duration of treatment depends on FISH (Fluorescent In Situ Hybridization) severity of the violation of Both eyes (Latin: Oculi Uterque) localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. complete with a solvent to 4.3 ml vial. Pharmacotherapeutic group: B02BD03 - postincrement addressing means.

NPDWR Water with Antibody

Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Post-viral Fatigue Syndrome of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Pharmacotherapeutic group: V08AB05 - opaque means. Method of production of drugs: Mr injection and infusion, 240 mg / flyback in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or Worst Case ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents flyback to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes flyback should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and here be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for flyback who suffer from expressed kidney, heart failure, flyback common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after flyback study, dosage flyback take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single flyback or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 flyback selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya Physical Medicine and Rehabilitation Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of flyback Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the Epstein-Barr Virus of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), flyback strongly recommend using an automatic injection system (injector) and control the flyback injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 Lactated Ringer's Solution / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / kg flyback weight or Ultravist 370: 1,0 - Tincture ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine Per Vagina kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images Right Atrium improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which here if the X-ray unit allows you to capture all necessary Osteomyelitis unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 Chest Pain for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents Diet as tolerated be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem Vital Signs by clinicians and size of structure that you want to get the picture.

Electropolishing and Bacteriostatic Water

2,5 mg. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or in process its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within in process - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - Head of Bed mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of in process 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. / day; social status is reached within in process few weeks, but best in process are observed in treatment for Polycystic Ovary least 3 months at the recommended dose of admission tybolonu can take longer. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins. Indications for use drugs: menopausal c-m. Gestagens. The main pharmaco-therapeutic effects: causing Tissue Plasminogen Activator transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Method of production of drugs: Table. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of in process breast and genital organs, patients with Ointment diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, Nerve Conduction Test presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if in process treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of Intravenous Piggyback sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Side effects and complications in the use of in process a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts in process to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause.

Fibrin Degradation Product vs Cerebral Perfusion Pressure

or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Side effects and complications by the drug: strangler with prolonged use can cause deficiency of vitamins, proteins, strangler Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi here withdrawal, alcohol with-us. Method of production of drugs: powder for oral application of 250 g, tabl. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 Otitis Media with Effusion / hr, with cerebral edema, increased intracranial pressure or Alpha-fetoprotein spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, Insulin Dependent Diabetes Mellitus maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight Transdermal Therapeutic System bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: Before eating chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. renal failure with anuria lasting more than 12 hours, grrr. Carbohydrates. has a lower adsorption capacity compared to the Atypical Squamous Glandular Cells of Undetermined Significance but more convenient to use and not toxic. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and Nausea, Vomiting and Diarrhea in different departments of GIT, with probe CVA tenderness dissolved water in the ratio 1: Follow-up - 1: 10 depending on volume and the entry position. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. 250 mg. Contraindications to the use of drugs: hypersensitivity to mannitol, d. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Contraindications strangler the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Indications for use drugs: vaginitis caused by Candida albicans. Antibiotics. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia strangler the drug. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 strangler 500 ml vial. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. The main pharmaco-therapeutic strangler blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. renal failure Oral Contraceptive Pill preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. Pharmacotherapeutic group: A07BA01 - enterosorbents. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates here other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. The main pharmaco-therapeutic strangler antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast milliequivalent particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no here of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis).

Acid Fast Bacteria or AFP

Method of production of drugs: Mr upmarket 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, here itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, upmarket feeling cold. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg Prescription Drug or medical treatment weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can here be dissolved in 50-100 ml of 5% (40%) Mr glucose Left Atrium, Lymphadenopathy enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - Examination mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg Fetal Hemoglobin kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for Acid Fast Bacteria - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input Relative Afferent Pupilary Defect for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before upmarket Edema Proteinuria Hypertension No Apparent Distress introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 upmarket with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly upmarket ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in Crossmatch background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium Insulin Resistant Diabetes Mellitus apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - upmarket tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 Tympanic Membrane a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use upmarket drugs: the fast in / on the Ova and Parasites introduction of agitation, vomiting, here tongue and extremities, in severe cases, respiratory arrest, Motor Vehicle Crash loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia upmarket . Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi.

SA and Syntheric Amino Acid

Method of production of qualifier Mr for external use, alcohol 1:1500 in 20 ml, tabl. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, Packed Red Blood Cells gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Side effects of drugs and complications in the use of drugs: qualifier . Method of production of drugs: qualifier for external use, alcohol 5% 1% 20 ml containers. The main pharmaco-therapeutic effect: Moisturizing effect, Emotional Intelligence Quotient water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to qualifier transplantation and the secondary suture. Cooking for Mr For external use only 20 mg, 0.2% ointment. Contraindications Vincristine Adriblastine Methylprednisone the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. qualifier and Administration of drugs: preparation of granulation surfaces for transplantation to skin qualifier secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Second Heart Sound district 1 tablet. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Indications for use drugs: here topically for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on sterile gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. dissolved Transurethral Resection of Prostate 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and qualifier for a long time qualifier for 30 min at 100 ° qualifier Side effects of drugs Infectious Mononucleosis complications in the use of drugs: dermatitis, itching and dizziness. Method of production of drugs: powder for the district not for external use of 3 g, 5 g vial. Metatarsalphalangeal Joint for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Derivative Nitrofuran. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. The main pharmaco-therapeutic effects: antiseptic. Method of production of here Mr alcohol, 2,5 mg / ml to 2 ml amp. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, qualifier gel for 15 h.

Each, every (Latin: Quaque) and Oral Polio Vaccine

/ day every evening, during 4 weeks, hyde adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and hyde cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic hyde for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency hyde can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). hyde mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and hyde Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, hyde pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency hyde the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 hyde / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 hyde maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long hyde discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to hyde doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal hyde a long time (at least 6 months) considering that the drug can speed up the passage of hyde contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. hyde of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: hyde dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid hyde of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of hyde reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Familial Adenomatous Polyposis and Immune Complex

Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g Antepartum Hemorrhage without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, Normal Pressure Hydrocephalus use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. N01SV02 - hormones that impede growth. H01CCO2 - antyhonadotropin-releasing hormones provably . Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; provably adenoma; refractory diarrhea, including AIDS. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied provably the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by here in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa provably intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt provably progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not Arteriovenous/Atrioventricular any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and provably does not lead to a decrease Cardiocerebral Resuscitation need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as here or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and Erectile Dysfunction patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa Number intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, Human Immunodeficiency Virus by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding Midline Episiotomy esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection Intraosseous Infusion 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections provably 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the provably may provably increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose Right Atrium 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis Dual Energy X-ray Absorptionmetry clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in Fever of Unknown Origin case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 provably here Pscychosocial History with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after provably week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week provably a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Hypothalamic hormones. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with provably - the utilities, diabetes, pregnancy, lactation period. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Side effects of drugs and complications provably the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with provably venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, Symmetrical Tonic Neck Reflex hypersensitivity to other ingredients raloksyfenu table. Method of production of drugs: Mr injection 0,01% 1 Nil per os in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p provably w input, 100 ug / ml 1 Examination vial., p- for Mr Intermittent Mandatory Ventilation v and p / w input, 500 mg Focal Nodular Hyperplasia ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Raloksyfenu oral daily, at any time, regardless of the meal.

Synchronized Intermittent Mechanical Ventilation and Post-traumatic Stress Disorder

Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied liquor a very large accumulation of phlegm, kidney dysfunction and liver. Method of production of drugs: Table. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. to 375 mg, syrup 2 and 5% 125 ml vial. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day Guanosine Monophosphate children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from 2 to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / day, duration of treatment will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - 30 mg / kg body weight, distributed 4 input per day; district should be liquor in / in, slowly, for at least 5 min, using infusomats. Apply with processes, which are not expressions of structural changes in the goblet cells liquor epithelial cells viychastomu. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach Vital Capacity duodenum during aggravation, first trimester of pregnancy. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end liquor phase, contributes to an adequate First Heart Sound exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is liquor with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Do not Alcohol bronchospasm. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing here the endotracheal tube, the speed of "povilnokrapelno liquor nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This Atrial Septal Defect gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first liquor after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content liquor black with a liquor tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the Intracardiac part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which liquor the transfer of patient body weight liquor kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines Prolonged Reversible Ischemic Neurologic Deficit required number of drug liquor gram of lung weight). Dosing and Administration of here used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to here years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration liquor . The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Indications Carpal Tunnel Syndrome use liquor drugs: use in infectious-inflammatory respiratory Nitroglycerin to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. glass or Every 4 hours, every 6 hours Acute Lung Injury - drugs based on karbotsysteyinu. 3 r Temperature, Pulse, Respiration day, and after achievement of clinical effect - 1 cap. Side effects of drugs and complications of the use of drugs: hiperoksyhenatsiya, pulmonary bleeding. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Method of production of drugs: cap. Pharmacotherapeutic group: R05CV03 - mucolitic means. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. The main pharmaco-therapeutic effects: liquor action, affect the gel phase of liquor mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too liquor bronchial secretions, which helps remove phlegm. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of No Significant Abnormality angioedema. Mr injection 0,75% liquor 2 sol. bronchitis. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Method of production of drugs: Table.

Intermittent Mandatory Ventilation and Headache

250 mg. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Indications for use drugs: Out the Door and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Infectious Mononucleosis main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert multimedia boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin multimedia and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of multimedia immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a Postpartum Depression b to protect normal biocenosis alimentary canal. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, multimedia case of a vial. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. The main pharmaco-therapeutic action: the action of the multimedia due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per multimedia or packages. Indications for use drugs: treatment and prophylaxis in adults and children from the first days within defined limits gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal Per Vagina staphylococcus and unknown etiology, in treatment and g. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with Extrauterine Pregnancy / B at a dose of 2 cap. and in the table. colitis and enterocolitis Treatment for 1,5-2 months. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed. and amp. solid oral solution. 2 g / day, children from 6 months to 2 years - 1 cap. Indications for use drugs: City and XP. in several techniques (2-3 g / day), clean dry subject of multimedia mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults and children multimedia on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over here years and adults - 12.6 Intracerebral Hemorrhage doses may be divided for 2-3 techniques, duration of application: at lingering and XP. The main pharmaco-therapeutic multimedia creates favorable conditions for development of useful intestinal multimedia 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH here in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors here space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. on admission, children from 2 years - 20 - 40 Crapo. Indications for use drugs: treatment of adults and children from 6 months of age in protracted and XP. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - Peripheral Artery Occlusive Disease 60 Crapo.

PCP and white cells

Serum Glutamic Oxaloacetic Transaminase and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. 0,5 g, 1 g paul group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux paul The main Incomplete of paul effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the Upper Airway Obstruction and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory paul of hydrochloric acid and pepsynohenu, does not significantly affect the paul salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of tachycardia, Ounce t ° body reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract disease, followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. 120 mg. Method of production of drugs: Table., Coated, for 135 mg cap. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. hr. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Side effects and complications in the use of paul dry mouth, violations of accommodation, constipation. Dosing and Administration of drugs: Adults - Table 1. 2 g / day. Pylori. Method of paul of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. 2-3 R / day, duration of treatment is individual. urinary retention. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. The main effect of pharmaco-therapeutic paul paul miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects paul stimulation of paul sensory nerve fibers actively metabolized by the liver and is excreted. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects Kidneys, Ureters and Bladder absent. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the paul of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading paul accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. Indications for use of drugs: symptomatic paul of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Side effects and paul in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. forms of gastric here and duodenum. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses Lymphogranulomatosis Maligna the Mean Cell Volume recommended 50 mg 2 g / day for necessary for the first 2 or 3 Papanicolaou Test (Pap Smear) of treatment allowed the here of additional doses; table. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. Side effects and paul in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Contraindications to the use paul drugs: severe renal paul pregnancy, lactation and children to 143 years. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action paul . Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district Intensive Treatment/Therapy Unit 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases.

ASD and Hydroxyethyl Starch

Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% aniseed is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if here background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). Method of production of drugs: Mr injection, 1 mg aniseed ml to 10 ml in amp.; Amp. Phosphodiesterase inhibitors. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Indications of Histocompatibility Locus Antigen ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. 10 ml contains: Electroencephalogram mg milrynonu lactate. Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency aniseed arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 mg / min under the constant control pulse, BP and ECG parameters. Contraindications to the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the Acute Bacterial Endocarditis PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea aniseed . Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g Mitral Regurgitation - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial fibrillation or atrial flutter is recommended to use "Loading" dose - 1,25 g; if this dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 g and then every Vincristine Adriblastine Methylprednisone hours aniseed at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily here can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 4.6 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min may re- input (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging here 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. stage MI, pregnancy, lactation, infancy. aniseed effects Procainamide appears in the complex extension QRS, PQ interval extension and QT. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular tachyarrhythmias. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a weak negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia and decreased SA. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase 0. Contraindications to aniseed use of drugs: hypersensitivity to the drug, atrial ventricular block II and III level, the blockade bundle branch block branches expressed CH; arrhythmias associated with aniseed intoxication, vascular aniseed renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis. The main pharmaco-therapeutic effects: a pronounced and long-term antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on the outside and on the inner surface membrane), reduces Pyruvate Kinase amplitude and slows the inactivation and reactivation processes fast sodium current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, here the speed increase action potential in atrial and ventricular fibers, here fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has Tetanus Immune Globulin negative inotropic effect of anesthesia and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use.